Literature DB >> 15925081

Erectile dysfunction and lower urinary tract symptoms secondary to BPH.

Kevin T McVary1.   

Abstract

INTRODUCTION: The relationship between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) have received increased attention recently because both diseases are highly prevalent, frequently co-associate in the same aging male group, and contribute significantly to the overall quality of life. The association between these two diseases has also garnered attention as investigators have hypothesized a common pathophysiology to explain the assertion that they are causally linked.
METHODS: A causal association between LUTS and ED cannot be established on the basis of the ever-increasing number of epidemiological studies. Attempting to explain a causal relationship between ED and LUTS needs to be examined using Hill's criterion, which is used by many epidemiologists to separate causal from non-causal explanations.
RESULTS: Given the epidemiological components of the Hill's Causality method, it is clear that there is a strong strength of association, internal consistency, and dose response effects between ED and LUTS. Because of the strong cross-sectional flavor to the epidemiological studies, the temporal relationships between ED and LUTS remain unknown. The issue of an "alternate explanation" to describe the LUTS-ED association appears to be accounted for in that several large studies have provided convincing multiple regression analyses in which the ED-LUTS relationship remains significant. The link between ED and LUTS has biologic plausibility given the four leading theories of how these diseases interrelate. These explanations fall into four theories each with a variable amount of supporting data. These include: (1) NOS/NO levels decreased or altered in the prostate and penile smooth muscle, (2) Autonomic hyperactivity effects on LUTS, prostate growth and ED., (3) increased Rho-kinase activation/endothelin activity, and (4) prostate and penile ischemia.
CONCLUSIONS: LUTS and sexual dysfunction are highly prevalent in aging men. Both conditions are also significant contributors to overall quality of life. New data has emerged to indicate potential links in epidemiological, physiologic, pathophysiologic and treatment aspects of these two entities.

Entities:  

Mesh:

Year:  2005        PMID: 15925081     DOI: 10.1016/j.eururo.2005.02.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  43 in total

1.  Relationship between lower urinary tract symptoms and metabolic syndrome in a Chinese male population.

Authors:  J G Pan; M Liu; X Zhou
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 2.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  The inter-relational effect of metabolic syndrome and sexual dysfunction on hypogonadism in type II diabetic men.

Authors:  N Amidu; W K B A Owiredu; C K Gyasi-Sarpong; H Alidu; B B Antuamwine; C Sarpong
Journal:  Int J Impot Res       Date:  2017-03-09       Impact factor: 2.896

4.  Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms.

Authors:  Gokhan Faydaci; Ugur Kuyumcuoglu; Bilal Eryildirim; Alper Aktas; Fatih Tarhan; Murat Tuncer
Journal:  Int Urol Nephrol       Date:  2010-11-04       Impact factor: 2.370

5.  Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract.

Authors:  Makoto Yono; Yasuhiro Yamamoto; Masaki Yoshida; Shoichi Ueda; Jamshid Latifpour
Journal:  Life Sci       Date:  2007-05-21       Impact factor: 5.037

6.  Discovering medical conditions associated with periodontitis using linked electronic health records.

Authors:  Mary Regina Boland; George Hripcsak; David J Albers; Ying Wei; Adam B Wilcox; Jin Wei; Jianhua Li; Steven Lin; Michael Breene; Ronnie Myers; John Zimmerman; Panos N Papapanou; Chunhua Weng
Journal:  J Clin Periodontol       Date:  2013-03-15       Impact factor: 8.728

Review 7.  Place of overactive bladder in male lower urinary tract symptoms.

Authors:  Osamu Yamaguchi; Ken Aikawa; Keiichi Shishido; Masanori Nomiya
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

8.  Prostatic profile, premature ejaculation, erectile function and andropause in an at-risk Mexican population.

Authors:  J Jaspersen-Gastelum; J A Rodríguez; F J Espinosa de los Monteros; L Beas-Sandoval; José Guzmán-Esquivel; D D Calvo; T Gutiérrez
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

9.  Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Authors:  V Favilla; G I Russo; G Reale; S Leone; T Castelli; S La Vignera; R A Condorelli; A E Calogero; S Cimino; G Morgia
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

Review 10.  Measurement of benign prostatic hyperplasia treatment effects on male sexual function.

Authors:  T A Skolarus; J T Wei
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.